Search
+
Read. Lead. Succeed. ET Prime - For Members Only
  • Sharp Insight-rich, Indepth stories across 20+ sectors
  • Access the exclusive Economic Times stories, Editorial and Expert opinion

Recent hit

From Kanjivarams to Thai trips: inside the toxic give-and-take between pharma companies and doctors

From Kanjivarams to Thai trips: inside the toxic give-and-take between pharma companies and doctors
From Kanjivarams to Thai trips: inside the toxic give-and-take between pharma companies and doctors
Getty Images

Synopsis

A well-intentioned attempt by the National Medical Commission to stop the practice of pharmaceutical companies offering inducements to doctors has been put in abeyance after an uproar. ET Prime found out that such inducements could range from consulting agreements to monetary transactions. Why is dismantling the decades-long cosy relationship based on mutual commercial benefits so difficult to dismantle?

Doctors have earned a place of reverence and high esteem in Indian society. They have been known to selflessly care for patients, a trait that was in ample display during the pandemic. Some of them even sacrificed their lives in the call of duty. But as happens in every profession, medical practice has its share of bad examples. An emotive subject, corruption in medical practice flares tempers and stokes heated debates. The topic made it to the
( Originally published on Aug 31, 2023 )
  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT
ET

Uh-oh! This is an exclusive story available for selected readers only.

Worry not. You’re just a step away.

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
  • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

The Economic Times